Ambu

Capital/Financing Update • Mar 8, 2013

Ambu – Debt capital market transaction

Today on Friday the 8th of March Ambu A/S plans to complete the debt capital market transaction as the market conditions announced in company announcement no. 13 2012/13 have proven to be favourable.

The total number of bonds issued is expected to amount to DKK 500 million with a duration of up to five years.

The above is subject to changes of terms and market conditions.

Contact

Lars Marcher, President & CEO, tel. +45 5136 2490, email: lm@ambu.com

Ambu A/S Baltorpbakken 13 DK-2750 Ballerup Tel. +45 7225 2000 CVR no.: 63 64 49 19 www.ambu.com

About Ambu

Since 1937, breakthrough ideas have driven our work to bring efficient healthcare solutions to life within our fields of excellence: Anaesthesia, Patient Monitoring & Diagnostics and Emergency Care. Millions of patients and healthcare professionals worldwide depend and rely on the functionality and performance of our products. We are dedicated to improving patient safety and determined to advance single-use devices. The manifestations of our efforts range from early inventions like the Ambu bag and the legendary Blue Sensor® electrodes to our latest landmark solutions such as the aScope™ – the world's first single-use videoscope. Our commitment to bringing new ideas and superior service to our customers has made Ambu one of the most recognised medical companies in the world. Our head office is situated in Ballerup near Copenhagen. Ambu has more than 1,700 employees in Europe, North America, Asia and the Pacific region. You can find more information about Ambu on our website: www.ambu.com.